Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 5240

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.18, p 0.639). This receipt's hash covers every field on it, plus the hash of receipt 5239, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 5240
    21 Oct 2026, 11:02 UTC

    TATDN1

    dopamine neurons, braak

    predictionTATDN1 in dopamine neurons tracks Braak Lewy-body stage

    registered0b87e71522bbf9be

    discovery+0.18 p=0.639 n=9

    replication+0.50 p=0.172 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.18, p 0.639)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    0f9189bd2e6b5fe911c1ae72…
    follows 15035699a5b6…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 5240: TATDN1 in dopamine neurons, braak

power
full sample +0.36 (p 0.145, n 18), 95% CI -0.13 to +0.71. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.41 (p 0.095, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.49 (p 0.037, n 18). not the mix.
skeptic
leave-one-out range +0.28 to +0.46, sign flips 0; without severely affected donors +0.36 (p 0.145, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for TATDN1 in dopamine neurons.

case closed: nothing better to follow up.